Scientists at deCODE genetics, a subsidiary of Amgen, reveal today in Nature Genetics associations between rare ...

The Eylea franchise was in need of a win after an appellate court last week denied the pharma’s bid to block Amgen’s ...

During a growth-fueled stock market sell-off, investors would typically expect the Dow to hold up a lot better than the S&P ...

Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio of products spanning ...

Robert Bradway, Amgen chairman and chief executive officer. Chairman and CEO of Onyx, Tony Coles, said that "we are pleased to have reached this agreement with Amgen, a company that shares Onyx's ...

NEW DELHI – U.S. drugmaker Amgen plans to invest approximately $200 million this year in its new technology center located in southern India, with additional investments anticipated, CEO Robert ...

Akari Therapeutics ( ($AKTX) ) has issued an announcement. On March 14, 2025, Akari Therapeutics announced the appointment of Mr. Abizer ...

LUND, SE / ACCESS Newswire / March 20, 2025 /Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) ...

Amgen has made a play in a hot area of immunology ... promising late-stage asset to treat atopic dermatitis," said Amgen CEO Robert Bradway. "We will take advantage of our two decades of ...

Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio ...